Health status impact on mortality and lung function decline in COPDGene smokers

W. Labaki (Ann Arbor, United States of America), T. Gu (Ann Arbor, United States of America), S. Murray (Ann Arbor, United States of America), J. Curtis (Ann Arbor, United States of America), X. Soler (San Diego, United States of America), S. Bhatt (Birmingham, United States of America), J. Bon (Pittsburgh, United States of America), T. Beaty (Baltimore, United States of America), J. Hokanson (Aurora, United States of America), D. Curran-Everett (Denver, United States of America), K. Lowe (Denver, United States of America), R. Bowler (Denver, United States of America), B. Make (Denver, United States of America), E. Regan (Denver, United States of America), F. Martinez (New York, United States of America), C. Hersh (Boston, United States of America), E. Silverman (Boston, United States of America), J. Crapo (Denver, United States of America), M. Han (Ann Arbor, United States of America)

Source: International Congress 2019 – Lung function evaluation and prognosis of airway diseases
Session: Lung function evaluation and prognosis of airway diseases
Session type: Oral Presentation
Number: 508
Disease area: Airway diseases

Congress or journal article abstractWebcastSlide presentation

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
W. Labaki (Ann Arbor, United States of America), T. Gu (Ann Arbor, United States of America), S. Murray (Ann Arbor, United States of America), J. Curtis (Ann Arbor, United States of America), X. Soler (San Diego, United States of America), S. Bhatt (Birmingham, United States of America), J. Bon (Pittsburgh, United States of America), T. Beaty (Baltimore, United States of America), J. Hokanson (Aurora, United States of America), D. Curran-Everett (Denver, United States of America), K. Lowe (Denver, United States of America), R. Bowler (Denver, United States of America), B. Make (Denver, United States of America), E. Regan (Denver, United States of America), F. Martinez (New York, United States of America), C. Hersh (Boston, United States of America), E. Silverman (Boston, United States of America), J. Crapo (Denver, United States of America), M. Han (Ann Arbor, United States of America). Health status impact on mortality and lung function decline in COPDGene smokers. 508

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Association between lung function decline and occupational exposures in patients with COPD
Source: International Congress 2017 – Shared exposures related to interstitial disease and airflow obstruction
Year: 2017

Estimating lung function decline and the effect of smoking in COPD patients
Source: Eur Respir J 2002; 20: Suppl. 38, 578s
Year: 2002

Lung function, smoking and mortality in a 26-year follow-up of healthy middle-aged males
Source: Eur Respir J 2005; 25: 618-625
Year: 2005



Six-year lung function observation and impact of smoking ban in healthy miners at high altitude (4000 meters)
Source: Annual Congress 2013 –World tour of tobacco epidemiology
Year: 2013


Does educational level influence lung function decline (Doetinchem Cohort Study)?
Source: Eur Respir J 2009; 34: 940-947
Year: 2009



Effects of lifetime smoking patterns on nutrition, muscular and lung function in early COPD patients from the PAC-COPD cohort study
Source: Eur Respir J 2007; 30: Suppl. 51, 283s
Year: 2007

Health indicators and inflammation - a comparison of stable smoking and ex-smoking COPD patients
Source: Eur Respir J 2005; 26: Suppl. 49, 52s
Year: 2005

The effects of socioeconomic status on health outcomes in patients with COPD
Source: International Congress 2016 – Non-inflammatory assessment of airway disorders
Year: 2016

Health status and gender predict time to next exacerbation in patients with COPD
Source: Annual Congress 2008 - Prognosis in COPD
Year: 2008

Lung function impairment, COPD hospitalisations and subsequent mortality
Source: Annual Congress 2009 - Exacerbations and characteristics of COPD
Year: 2009

Gender impact on associations between socioeconomic status and lung function decline in a general population
Source: Annual Congress 2008 - COPD - clinical and epidemiological aspects
Year: 2008


Regional lung function in nonsmokers and asymptomatic current and former smokers
Source: ERJ Open Res, 5 (3) 00240-2018; 10.1183/23120541.00240-2018
Year: 2019



Influence of smoking on respiratory function and status of proteinas-inhibitory system in patients COPD
Source: International Congress 2014 – Passive smoking, active smoking and COPD
Year: 2014


Associations between lung function and dyspnoea, self-rated health, and mortality: the Nord-Trondelag health study
Source: Annual Congress 2008 - Outcome and trends in obstructive lung disease (OLD) and cardiovascular relation to OLD
Year: 2008



Changes in performance status in continued smokers vs quitters after a diagnosis of lung cancer: a cohort study
Source: Virtual Congress 2020 – The role of health care systems in treating tobacco dependence
Year: 2020


LATE-BREAKING ABSTRACT: Five items from the CAT questionnaire identify smokers with preserved lung function at higher risk for poor respiratory outcomes: An analysis of the SPIROMICS cohort
Source: International Congress 2016 – Biomarkers and phenotypes of COPD
Year: 2016


Is physical activity a determinant for change in FEV1 in COPD patients? A prospective cohort study
Source: International Congress 2015 – Best abstracts in physical activity in chronic lung diseases
Year: 2015

Cardiovascular comorbidities based on impaired pulmonary function in non-smoking population
Source: Virtual Congress 2020 – Airflow obstruction, COPD and comorbidities
Year: 2020


Corerelation of COPD exacerbation with comorbidities, Lung function and mortality within a single-practice primary-care cohort in the UK
Source: International Congress 2019 – Multimorbidity in airway diseases and appropriate inhaled corticosteroid use in COPD
Year: 2019


Socioeconomic risk factors for lung function decline in a general population
Source: Eur Respir J 2010; 36: 480-487
Year: 2010